$1.77 -$0.01 (-0.6%)

11:48 AM EDT on 10/21/19

MEI Pharma, Inc. (NASDAQ:MEIP)

CAPS Rating: 2 out of 5

A development stage company, engaged in the clinical development of the anti-cancer drug phenoxodiol.

Current Price $1.77 Mkt Cap $131.1M
Open $1.76 P/E Ratio 0.00
Prev. Close $1.78 Div. (Yield) $0.00 (0.0%)
Daily Range $1.75 - $1.79 Volume 63,490
52-Wk Range $1.44 - $3.41 Avg. Daily Vol. 240,722

Caps

How do you think NASDAQ:MEIP will perform against the market?

Add Stock to CAPS Watchlist

All Players

58 Outperform
20 Underperform
 

All-Star Players

16 Outperform
12 Underperform
 

Wall Street

2 Outperform
0 Underperform
 

Top NASDAQ:MEIP Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

tharlow (92.26)
Submitted November 09, 2007

This company has a portfolio of next-generation cancer drugs with blockbuster potential. Look no further for the next Genentech.

zzlangerhans (99.81)
Submitted February 15, 2013

Thanks to a low float after a reverse split, MEI stock is bobbing around like a cork in the ocean. After cutting loose from Novogen and their failed plant flavonoid technology, MEI needed to find a new reason to exist and continue paying inflated… More

NASDAQ:MEIP VS S&P 500 (SPY)

Fools bullish on NASDAQ:MEIP are also bullish on:

Fools bearish on NASDAQ:MEIP are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about MEIP.

Recs

0
Member Avatar eltonjd04 (< 20) Submitted: 6/30/2015 8:15:41 AM : Outperform Start Price: $1.72 NASDAQ:MEIP Score: -41.63

People like to take their medication and this Pharma should become an outstanding supplier of their needs and therefore they should not go under, but they should excel. At least i feel that they will. JDE

Recs

0
Member Avatar Deepvaluestocks (< 20) Submitted: 6/30/2015 12:56:39 AM : Outperform Start Price: $1.72 NASDAQ:MEIP Score: -41.63

With over $70 million in cash as of Q1 end, a market cap of less than $60 million, ample catalysts the rest of the year, and lack of market attention to ME-344 and PWT143, I view MEI Pharma as an attractive stock to buy at current levels.

Recs

0
Member Avatar oscillation (68.30) Submitted: 4/2/2015 10:12:58 AM : Outperform Start Price: $1.79 NASDAQ:MEIP Score: -45.73

nev

Leaderboard

Find the members with the highest scoring picks in MEIP.

Score Leader

nicvo

nicvo (98.58) Score: +274.29

The Score Leader is the player with the highest score across all their picks in MEIP.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
AgentFlashcool 21.01 10/1/2008 Underperform NS $9.72 -81.79% +166.71% +248.50 0 Comment
Ruckwerts 59.29 9/30/2011 Underperform 3M $8.86 -80.01% +160.90% +240.92 0 Comment
tcampbellla 83.83 9/10/2008 Underperform 5Y $16.08 -88.99% +149.39% +238.38 1 Comment
nicvo 98.58 7/8/2008 Underperform 5Y $10.02 -82.34% +145.90% +228.23 0 Comment
toorima 98.24 7/9/2008 Underperform 3M $9.42 -81.21% +142.44% +223.65 0 Comment
soundsound 91.07 4/11/2008 Underperform 5Y $16.20 -89.07% +130.71% +219.79 0 Comment
joesteinhardt 30.05 4/11/2008 Underperform 3M $15.60 -88.65% +130.70% +219.35 0 Comment
igetmoney2010 < 20 6/10/2008 Underperform NS $18.00 -90.17% +128.98% +219.14 0 Comment
qubit16 88.79 12/4/2007 Underperform NS $15.96 -88.91% +114.00% +202.91 0 Comment
KramerHead 22.46 6/4/2007 Underperform 5Y $19.26 -90.81% +105.62% +196.43 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackStifel 91.16 7/27/2018 Outperform NS $3.88 -54.38% +5.59% -59.97 0 Comment
TrackMuhlenkamp 50.20 9/30/2007 Outperform NS $18.72 -90.54% +105.71% -196.25 2 Comments